ASCO GI 2019: Post-Conference News on CRC - Episode 3

Lack of Durable Responses in Current Treatment of mCRC

Insight on the ongoing unmet needs in achieving durable responses in BRAFV600E-mutant metastatic colorectal cancer (mCRC).